Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $36.96 | 52-week high | $170.47 |
| Prev. close | $35.89 | 52-week low | $31.94 |
| Day low | $36.00 | Volume | 664,255 |
| Day high | $37.21 | Avg. volume | 11,216,274 |
| 50-day MA | $40.87 | Dividend yield | N/A |
| 200-day MA | $85.00 | Market Cap | 14.22B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Price Returns
| 1-mo | -6.64% |
| 3-mo | -30.00% |
| 6-mo | -69.73% |
| 1-year | -63.74% |
| 3-year | -76.91% |
| 5-year | 75.00% |
| YTD | -11.11% |
| 2024 | -58.19% |
| 2023 | -44.63% |
| 2022 | -29.28% |
| 2021 | 143.11% |
| 2020 | 434.10% |
Loading social stream, please wait...